Trial Profile
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Four-Week Study to Assess the Efficacy and Safety of HKT-500 in Subjects With Pain Caused by Mild to Moderate Osteoarthritis of the Knee.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jun 2015
Price :
$35
*
At a glance
- Drugs Ketoprofen (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- Sponsors Hisamitsu Pharmaceutical
- 01 Dec 2008 New trial record.